2024-10-21T19:35:00-07:00 2023-12-31 371420474 Fontanello Duffield & Otake LLP 44 Montgomery Street Suite 1305 San Francisco CA 94104 990 2023-01-01 930988840 National Eczema Association NATI 4154993474 505 San Marin Drive B300 Novato CA 94945 Kristin Belleson CEO 2024-10-21 false true Erik Satow P01410341 4159830200 2023 2024-10-15 13:58:12Z Julie Block 12697922 false X www.nationaleczema.org X 1988 CA NEA is the driving force for an eczema community fueled by knowledge, strengthened through collective action and propelled by the promise of a better future. 9 9 33 450 807051 468475 4151638 3748923 2932065 3635456 -21627 -173298 1177 1045 7063253 7212126 702733 616101 0 3339890 4373497 0 697140 2517716 3132931 6560339 8122529 502914 -910403 9108280 8910198 605745 397879 8502535 8512319 NEA is the driving force for an eczema community fueled by knowledge, strengthened through collective action and propelled by the promise of a better future. false false 6245151 3635456 Eczema research we doNEAs research team seeks to understand the unique experiences of people with eczema. In 2023, we launched a survey to learn about the burden and unmet needs for types of eczema other than atopic dermatitis. It is our hope that this new data will lead to better care and support.Eczema Expo 2023 in Orlando, FL Eczema Expo is our annual conference and our favorite weekend of the year! We welcomed more than 350 community members to Expo in June 2023. They learned from world-class experts, physicians and researchers about the latest in eczema research and drug development. They also bonded over shared stories and created a community of support and connection. Survey results showed that 88% of attendees felt more connected to the eczema community. Were excited about Eczema Expo in Denver, CO, from June 2730, 2024.Seal of Acceptance adds two new categoriesNEAs Seal of Acceptance is an emblem that certifies that a product has undergone rigorous testing and scientific review where its ingredients and formulation data meet Seal standards for sensitivity, irritation and toxicity. People with eczema rely on the Seal to help inform their choice of personal care and household products. NEA recently added lip care and deodorant categories to better help our community live well with eczema.NEA Ambassadors take actionLast year, NEA Ambassadors participated in nearly 200 advocacy, research or awareness events. They shared their stories with staff at more than 100 legislative offices and asked for support of the Safe Step Act and the HELP Copays Act, which advocate for better access to eczema care. Their efforts resulted in six new cosponsors for these Acts.EczemaWiseEczemaWise is the free eczema tracker app to help manage eczema between doctor visits. For the second year, EczemaWise received multiple top prizes from the eHealthcare Leadership awards. EczemaWise received the Silver prize for Best Mobile App, Best Care/Disease Management and Best Email Content.Eczema Awareness Month 2023For Eczema Awareness Month, NEA featured stories from people with eczema on a billboard in the famous Times Square in New York City! These stories and more were featured in our #onethingabouteczema social media campaign. These posts and videos received nearly 5 million impressions and resulted in greater awareness of eczema. 616101 616101 Eczema research we fundLast year, NEA celebrated the 20th anniversary of our research program by awarding nearly $1 million in grants to eczema researchers. Their research will explore the many facets of eczema, including the science behind itch and inflammation, psychosocial burden and new pathways for potential therapies. 6861252 true true false false false false false false false false true false false false true true true false false false true true false false false false false true true true false false false false false false false false false false false false false false false false false true 91 0 true 33 true true true false false false false false false 0 false false false false false false false X 9 9 false false false false false false false true true false false true true true true true true true false false AK AR AZ CA CT FL GA IL KS KY LA MD ME MI MN MO MS NC NH NY OH OR PA RI SC UT VA WA WI WV X X X Julie Block 4154993474 505 San Marin Drive Ste B300 Novato CA 94945 X Julie Block CEO 40.00 0.00 298000 0 63664 Wendy Smith Begolka VP Scientific Affr 40.00 0.00 219167 0 37261 Scott Sanford COO 40.00 0.00 206000 0 31455 Amber Whiteside Dir Mkting & Com 40.00 0.00 180083 0 26398 Melody Sugg VP Philanthropy 40.00 0.00 184000 0 18698 Christina Crowley Chairwoman 2.00 0.00 X X 0 0 0 Ashley Keyes Jacobs Director 2.00 0.00 X 0 0 0 Amy Chrnelich Secretary 2.00 0.00 X X 0 0 0 Nathan Jetter Director 2.00 0.00 X 0 0 0 Lisa Choy Director 2.00 0.00 X 0 0 0 Lynell Doyle Director 2.00 0.00 X 0 0 0 Mike Bristol Director 2.00 0.00 X 0 0 0 Peter Lio Director 2.00 0.00 X 0 0 0 Sarah Young O'Donnell CFO 2.00 0.00 X X 0 0 0 Mary Quazzo Director 2.00 0.00 X 0 0 0 Dinesh Shenoy Director 2.00 0.00 X 0 0 0 Lisa Butler Sr VP Strat Prg 40.00 0.00 0 0 0 Isabelle Thibau Assoc. Dir, Data 40.00 0.00 0 0 0 1087250 177476 19 false true false Hida Visuals 8732 Wyngate St Sunland CA 91040 Video Production 150311 Unosquare LLC 10260 SW Greenburg Road Suite 400 Portland OR 97223 Software Dev 509086 2 3748923 3748923 Patient Forums 784559 784559 Publications 807051 807051 Seal of Acceptance 2043846 2043846 3635456 144137 144137 0 0 0 5168361 5485796 -317435 -317435 -317435 1045 1045 0 0 0 7212126 2510970 807051 144137 317020 317020 82622 82622 216459 216459 0 599119 476871 38795 83453 0 2916312 2335474 172131 408707 0 610011 476557 50057 83397 248055 198444 14883 34728 0 16605 6630 9450 525 96741 38627 55057 3057 0 0 0 90671 36204 51602 2865 0 42007 33606 2520 5881 265322 238790 13266 13266 0 142447 116018 6126 20303 152316 146224 3046 3046 0 0 0 0 396162 396162 22567 18054 1354 3159 Program & Awareness Events 1344443 1344443 Recruiting & Development 131430 131430 Taxes, Licenses & Fees 122979 96827 10494 15658 Research Expenses 118751 118751 190490 167469 3926 19095 8122529 6861252 564137 697140 1877922 1407818 0 0 810776 631090 0 0 0 0 124 68 254703 366020 254703 4662254 4971923 0 0 1379584 1632996 11600 11600 9108280 8910198 15722 71748 200000 50000 390023 276131 605745 397879 X 8322667 8352599 179868 159720 8502535 8512319 9108280 8910198 -910403 908987 11200 X false true X true false X 2096224 3553306 3688366 4151638 3748923 17238457 0 0 2096224 3553306 3688366 4151638 3748923 17238457 6443690 10794767 64171 83941 77024 146022 144137 515295 0 0 17753752 0.60800 0.42790 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 254703 254703 254703 Lease Obligation - Current 137490 Lease Obligation - Long Term 138641 276131 X 7212126 7212126 7212126 8122529 8122529 8122529 Part X : FIN48 Footnote The Organization adopted the recognition requirements for uncertain income tax positions as required by generally accepted accounting principles, with no cumulative effect adjustment required. Income taxbenefits are recognized for income tax positions taken or expected to be taken in a tax return, only when it is determined that the income tax position will more-likely-than-not be sustained upon examination by taxing authorities. The Organization has analyzed tax positions taken for filing with the Internal Revenue Service and all state jurisdictions where it operates. The Organization believes that income tax filing positions will be sustained upon examination and does not anticipate any adjustments that would result in a material adverse effect on the Organizations financial condition, results of operations or cash flows. Accordingly, the Organization has not recorded any reserves, or relatedaccruals for interest and penalties for uncertain income tax positions at December 31, 2023. The Organization is subject to routine audits by taxing jurisdictions; however, there are currently no auditsfor any tax periods in progress. true North America 0 0 Research Grant Research Grant 101666 Europe 0 0 Research Grant Research Grant 114793 216459 216459 Europe Research 114793 Wire North America Research 15000 Wire North America Research 33333 Wire North America Research 53333 Wire 4 false false false false false false Part I, Line 2 - Grantmakers Explanation For Monitoring Use of Funds Outside US Grants are awarded based upon recommendations of independent peer review committee which evaluates responses to requests for proposals. A portion of grant award is paid when contract is signed. Final payment is not made until peer review committee approves final report. true Boston Childrens Hospital 300 Longwood Ave Boston MA 02115 042774441 31903 0 Research Emory University 201 Dowman Drive Atlanta GA 30322 580566256 66666 0 Research MA General Hospital PO Box 414876 Boston MA 02114 041564655 50002 0 Research Phoenix Childrens Hospital 1919 E Thomas Rd Phoenix AZ 85016 860422559 16667 0 Research UC San Diego 9500 Gilman Dr La Jolla CA 92093 956006144 50001 0 Research UC San Francisco 505 Parnassus Ave San Francisco CA 94143 946036493 66624 0 Research UMass Chan Medical School 55 Lake Avenue North Worcester MA 01655 043108190 16845 0 Research University of Texas 110 Inner Campus Drive Austin TX 78705 746000203 8327 0 Research 8 0 Scholarships 43 75322 N/A Honorariums 13 7000 N/A Research Grant 1 300 N/A Grantmaker's Description of How Grants are Used Grants are awarded based upon recommendations of independent scientific advisory committee which evaluates responses to request for proposal. One third of the grants are paid when contract is signed, one third upon submission of six month progress report, and the remainder paid upon submission of final report. true X X X false false false false false false false false false Amber Whiteside Dir Mkting & Com 180083 26398 206481 Julie Block CEO 298000 63664 361664 Melody Sugg VP Philanthropy 184000 18698 202698 Scott Sanford COO 206000 31455 237455 Wendy Smith Begolka VP Scientific Affr 219167 37261 256428 Form 990, Part VI, Section B, Line 11b Form 990 is reviewed by directors at meeting scheduled for that purpose, return preparer is available to explain form and answer questions. Form 990, Part VI, Section B, Line 12c Officers and directors complete an annual disclosure statement. Form 990, Part VI, Section B, Line 15a Compensation is determined by reference to performance and comparable organizations based on data published by the National Health Council. Form 990, Part VI, Section C, Line 19 Available upon request.